<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03592524</url>
  </required_header>
  <id_info>
    <org_study_id>Ramadan fasting and liver</org_study_id>
    <nct_id>NCT03592524</nct_id>
  </id_info>
  <brief_title>Effect of Ramadan Fasting on Muslim Recipients After Living Donor Liver Transplantation</brief_title>
  <official_title>Effect of Ramadan Fasting on Muslim Recipients After Living Donor Liver Transplantation: Single Center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to assess the possibility of Ramadan fasting and to start protocol of&#xD;
      adapting immunosupression regiment and scheduled follow up for patients wishing to fast after&#xD;
      liver transplantation (LT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Very limited data in the literature about how to apply Ramadan fasting in the post liver&#xD;
      transplant setting. The timing of Ramadan is changeable according to the lunar year and&#xD;
      according to time of down and sunset in each country. In Egypt, for example, Ramadan fasting&#xD;
      this year started 17th of May and finished 14th June with average fasting hours of 15-16&#xD;
      hours The study aimed to assess the possibility of Ramadan fasting and to start protocol of&#xD;
      adapting immunosupression regiment and scheduled follow up for patients wishing to fast after&#xD;
      LT.This prospective study included 45 recipients who underwent LT at Ain Shams Center for&#xD;
      Organ Transplant (ASCOT), Cairo, Egypt.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 17, 2018</start_date>
  <completion_date type="Actual">June 21, 2018</completion_date>
  <primary_completion_date type="Actual">June 14, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of fasting on Allograft function among recipients post liver transplantation</measure>
    <time_frame>1 month</time_frame>
    <description>Comparison between pre and post fasting state as regards allograft lfunctions , reflected by measuring AST, ALT(liver enzymes) , serum bilirubin , serum albumin +\_ liver biopsy if rejection is suspected</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of fasting Ramadan on renal functions among recipients post liver transplantation</measure>
    <time_frame>1 month</time_frame>
    <description>Comparison between fasting and post fasting renal functions ( serum creatinine, Blood urea nitrogen ,serum sodium and potassium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effect of Ramadan fasting on immunosuppressant trough level in liver transplantation recipients</measure>
    <time_frame>1 month</time_frame>
    <description>Comparison between fasting and post fasting immunosuppressant drugs trough levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Ramadan fasting on blood pressure Among hypertensive recipients on antihypertensive drugs</measure>
    <time_frame>1 month</time_frame>
    <description>For hypertension patients regular monitoring of blood pressure by sphingomanometer for any changes in these parameters on daily bases during the months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of fasting Ramadan on blood sugar control among diabetics recipients</measure>
    <time_frame>1 month</time_frame>
    <description>Comparison between fasting and post fasting on blood sugar by daily measures of fasting and 2 hours postprandial blood sugar</description>
  </secondary_outcome>
  <enrollment type="Actual">45</enrollment>
  <condition>Liver Transplantation</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Fasting Ramadan</intervention_name>
    <description>Muslims recipients refrain from eating and drinking anything from dawn until sunset(14-15 hours)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients underwent Living donor liver transplantation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Recipients completed their first year after LDLT&#xD;
&#xD;
               -  Normal liver and renal functions at least in the last 3 months before fasting&#xD;
&#xD;
               -  No reported rejection episodes in the last 6 months before the study&#xD;
&#xD;
               -  Recipients wishing to fast Ramadan&#xD;
&#xD;
               -  Informed consent about the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • First year of LDLT&#xD;
&#xD;
               -  Recipients transplanted for Budd Chiari syndrome&#xD;
&#xD;
               -  Recipients with vascular stents (hepatic artery , portal vein or hepatic vein&#xD;
                  stents) requiring long life anticoagulation&#xD;
&#xD;
               -  Creatinine clearance &lt;60 ml/min or serum creatinine &gt;1.5 mg/dl at time of initial&#xD;
                  enrolment in the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Iman Montasser</name>
      <address>
        <city>Cairo</city>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 22, 2018</study_first_submitted>
  <study_first_submitted_qc>July 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2018</study_first_posted>
  <last_update_submitted>July 18, 2018</last_update_submitted>
  <last_update_submitted_qc>July 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Iman Fawzy Montasser</investigator_full_name>
    <investigator_title>Associate professor of tropical medicine , Ain Shams university</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

